Team
EDUCATION AND TRAINING
BIOGRAPHY
Daisy received her B.S. from the University of Vermont where she studied Microbiology. At UVM, Daisy worked in the laboratory of Dr. Yvonne Janssen-Heininger where she studied the role of different cytokines in allergic asthma. Daisy completed her Ph.D. in Dr. Benjamin tenOever’s laboratory at the Icahn School of Medicine at Mount Sinai where she studied the host response to SARS-CoV-2 infection to inform the development of therapeutics by characterizing the golden hamster model. She is currently a postdoctoral researcher in Dr. Ruth Franklin’s laboratory at Harvard Medical School where she studies regulation of innate immune responses in the lung and the role of macrophages in repair of viral infection-induced damage throughout the respiratory tract.
PUBLICATIONS
SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery
Justin J Frere, Randal A Serafini, Kerri D Pryce, Marianna Zazhytska, Kohei Oishi, Ilona Golynker, Maryline Panis, Jeffrey Zimering, Shu Horiuchi, Daisy A Hoagland, Rasmus Møller, Anne Ruiz, Albana Kodra, Jonathan B Overdevest, Peter D Canoll, Alain C Borczuk, Vasuretha Chandar, Yaron Bram, Robert Schwartz, Stavros Lomvardas, Venetia Zachariou, Benjamin R tenOever
10.1101/2022.01.18.476786 28/09/2022
PMID: 35857629
A translational genomics approach identifies IL10RB as the top candidate gene target for COVID-19 susceptibility
Georgios Voloudakis, James M. Vicari, Sanan Venkatesh, Gabriel E. Hoffman, Kristina Dobrindt, Wen Zhang, Noam D. Beckmann, Christina A. Higgins, Stathis Argyriou, Shan Jiang, Daisy Hoagland, Lina Gao, André Corvelo, Kelly Cho, Kyung Min Lee, Jiantao Bian, Jennifer S. Lee, Sudha K. Iyengar, Shiuh-Wen Luoh, Schahram Akbarian, Robert Striker, Themistocles L. Assimes, Eric E. Schadt, Julie A. Lynch, Miriam Merad, Benjamin R. tenOever, Alexander W. Charney, Mount Sinai COVID-19 Biobank, VA Million Veteran Program COVID-19 Science Initiative, Kristen J. Brennand, John F. Fullard & Panos Roussos
NPJ genomic medicine, 2022 7(1), 52. 05/09/2022
Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia
Zazhytska M, Kodra A, Hoagland DA, Frere J, Fullard JF, Shayya H, McArthur NG, Moeller R, Uhl S, Omer AD, Gottesman ME, Firestein S, Gong Q, Canoll PD, Goldman JE, Roussos P, tenOever BR, Jonathan B Overdevest, Lomvardas S
10.1016/j.cell.2022.01.024 02/02/2022
PMID: 35180380
Non-cell autonomous disruption of nuclear architecture as a potential cause of COVID-19 induced anosmia.
Zazhytskka M, Kodra A, Hoagland DA, Frere J, Fullard JF, Shayya H, McArthur NG, Moeller R, Uhl S, Omer AD, Gottesman ME, Firestein S, Gong Q, Canoll PD, Goldman JE, Roussos P, tenOever BR, Overdevest JB, Lomvardas S.
Cell 01/02/2022
PMID: Pending